Research Study Available

2b Clinical Study For NF1 Patients with Cutaneous Neurofibromas

Who Can Participate: Ages 18+, Diagnosed with neurofibromatosis type 1, have 10 clinically diagnosed cNF’s, 2 cutaneous neurofibromas on face.

Objective: The purpose of this study is to test the safety and effectiveness of 2 concentrations of NFX-179 gel compared with placebo gel in reducing the appearance of cutaneous neurofibromas (cNFs) in subjects with Neurofibromatosis Type 1 (NF1).

Contact: To see if you qualify for this investigational study, please fill out this form here